Analysis of allosterism in functional assays

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 2, 2005, Pages 740-754

  Ehlert, Frederick J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RECEPTOR;

AGONIST; ALLOSTERISM; ANALYTIC METHOD; ARTICLE; CONCENTRATION RESPONSE; DISSOCIATION CONSTANT; MATHEMATICAL ANALYSIS; NONLINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; THEORETICAL STUDY;

ALGORITHMS; KINETICS; MODELS, CHEMICAL; MODELS, STATISTICAL; NONLINEAR DYNAMICS; RECEPTORS, DRUG; REGRESSION ANALYSIS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 27144491979     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.090886     Document Type: Article

References (22)

1. Black JW and Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B 220:141-162.
2. Burgen AS (1981) Conformational changes and drug action. Fed Proc 40:2723-2728.
3. Christopoulos A (2000) Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays, in Current Protocols in Pharmacology (Enna SJ ed), John Wiley & Sons, Inc., New York.
4. Christopoulos A (2002) Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1:198-210.
5. Clark AL and Mitchelson F (1976) The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol 58:323-331.
6. Ehlert FJ (1986) 'Inverse agonists', cooperativity and drug action at benzodiazepine receptors. Trends Pharmacol Sci 7:28-32.
7. Ehlert FJ (1988a) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 33:187-194.
8. Ehlert FJ (1988b) Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. J Pharmacol Exp Ther 247:596-602.
9. Ehlert FJ (2000) Ternary complex model, in Biomedical Applications of Computer Modeling (Christopoulos A ed) pp 21-85, CRC Press, Boca Raton, FL.
10. Ehlert FJ and Griffin MT (2001) Estimation of agonist activity and relative efficacy at G protein-coupled receptors: mutational analysis and characterization of receptor subtypes. Anal Pharmacol 2:34-48.
11. 3 muscarinic receptors in guinea pig ileum and transfected cells. J Pharmacol Exp Ther 289:981-992.
12. Furchgott RF (1966) The use of b-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 3:21-55.
13. Hall DA (2000) Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation. Mol Pharmacol 58:1412-1423.
14. Hammer R, Giraldo E, Schiavi GB, Monferini E, and Ladinsky H (1986) Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci 38:1653-1662.
15. Kenakin TP (1997) Pharmacologic Analysis of Drug-Receptor Interaction, Lippincott-Raven Publishers, Philadelphia.
16. Kenakin TP and Beek D (1982) In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure. J Pharmacol Exp Ther 220:77-85.
17. Lazareno S and Birdsall NJ (1995) Detection, quantitation and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
18. Mackay D (1981) An analysis of functional antagonism and synergism. Br J Pharmacol 73:127-134.
19. Riker WF Jr and Wescoe WC (1951) The pharmacology of Flaxedil, with observations on certain analogs. Ann NY Acad Sci 54:373-394.
20. Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11:379-393.
21. Stockton JM, Birdsall NJ, Burgen AS, and Hulme EC (1983) Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23:551-557.
22. Walton FA (1950) Flaxedil, a new curarizing agent. Can Med Assoc J 63:123-129.